Open Journal of Blood Diseases

Volume 3, Issue 4 (December 2013)

ISSN Print: 2164-3180   ISSN Online: 2164-3199

Google-based Impact Factor: 0.62  Citations  

Splenic Marginal Zone Lymphoma in a Patient with Positive Hepatitis B Virus Serology*

HTML  XML Download Download as PDF (Size: 115KB)  PP. 105-107  
DOI: 10.4236/ojbd.2013.34021    4,388 Downloads   8,276 Views  


We present a case in which an elderly woman diagnosed with a splenic marginal zone lymphoma (MZL) was found to have positive Hepatitis B serology. Link with Hepatitis C virus is well documented but reports of association of Hepatitis B virus (HBV) with splenic marginal zone lymphoma are still emerging. A 69-year-old lady presented with weight loss, pancytopenia and marked splenomegaly. Prior to commencing treatment, Hepatitis B serology confirmed Hepatitis B infection. She was treated with Chlorambucil along with anti-hepatitis B prophylaxis and HBV PCR monitoring. She had an excellent response to treatment with resolution of symptoms and splenomegaly. This case highlights the importance of testing for hepatitis B serology in patients diagnosed with splenic MZLs as causative agent. Although the association between HCV is well documented in the literature, a relationship between HBV may also be important. Also, chemotherapy +/- Rituximab for splenic MZL is associated with the reactivation of latent infections; hence providing prophylactic cover for pre-existing latent HBV infection may be required to prevent reactivation as in this case.

Cite this paper

Q. Iman, E. Dewi and B. Syed, "Splenic Marginal Zone Lymphoma in a Patient with Positive Hepatitis B Virus Serology*," Open Journal of Blood Diseases, Vol. 3 No. 4, 2013, pp. 105-107. doi: 10.4236/ojbd.2013.34021.

Cited by

No relevant information.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.